Why is Glaxosmithkline Pharmaceuticals Ltd ?
1
Poor long term growth as Net Sales has grown by an annual rate of 3.62% and Operating profit at 15.07% over the last 5 years
2
Flat results in Mar 26
3
With ROE of 45, it has a Very Expensive valuation with a 17.9 Price to Book Value
- The stock is trading at a fair value compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -15.64%, its profits have risen by 10.5% ; the PEG ratio of the company is 3.8
4
Underperformed the market in the last 1 year
- Even though the market (BSE500) generated negative returns of -0.97% in the last 1 year, its fall in the stock was much higher with a return of -15.64%
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Glaxosmi. Pharma for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Glaxosmi. Pharma
-15.64%
-0.53
29.26%
Sensex
-7.45%
-0.58
13.01%
Quality key factors
Factor
Value
Sales Growth (5y)
3.62%
EBIT Growth (5y)
15.07%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-1.21
Sales to Capital Employed (avg)
1.97
Tax Ratio
26.32%
Dividend Payout Ratio
91.89%
Pledged Shares
0
Institutional Holding
12.31%
ROCE (avg)
-239.91%
ROE (avg)
45.70%
Valuation Key Factors 
Factor
Value
P/E Ratio
40
Industry P/E
35
Price to Book Value
17.86
EV to EBIT
30.37
EV to EBITDA
28.83
EV to Capital Employed
-78.42
EV to Sales
9.88
PEG Ratio
3.79
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
45.02%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
No Trend






